$5.08
▲ +0.2% Today
as of Sep 11, 11:32 ET
Last 30 days
Recent Press Releases & News
Champions Oncology (CSBR) Q1 2027 Earnings Call Transcript
Champions Oncology Q1 Earnings Call Highlights
Champions Oncology Reports Revenue of $15.2 Million
Overview
52-week range
$4.83
$8.74
6% of range
Avg surprise (last 0)
—
Avg reaction (last 1)
-1.3%
0% positive
Latest IV / EM
426%
EM ±50.3% · $5 · Sep 18
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Sat Jan 31, 2026 | Jan 2026 | $-0.02 | — | — | — | — | financials |
| Mon Sep 15, 2025 | Jul/2025 | $-0.03 | — | — | — | — | earnings |
| Wed Jul 23, 2025 | Apr/2025 | $-0.13 | — | — | — | -1.3% | earnings |
| Fri Jan 31, 2025 | Jan 2025 | $0.31 | — | — | — | — | financials |
| Thu Oct 31, 2024 | Oct 2024 | $0.05 | — | — | — | — | financials |
| Wed Jul 31, 2024 | Jul 2024 | $0.09 | — | — | — | — | financials |
| Wed Jan 31, 2024 | Jan 2024 | $-0.19 | — | — | — | — | financials |
| Tue Oct 31, 2023 | Oct 2023 | $-0.15 | — | — | — | — | financials |
| Mon Jul 31, 2023 | Jul 2023 | $-0.19 | — | — | — | — | financials |
| Tue Jan 31, 2023 | Jan 2023 | $-0.18 | — | — | — | — | financials |
| Mon Oct 31, 2022 | Oct 2022 | — | — | — | — | — | financials |
| Sun Jul 31, 2022 | Jul 2022 | $-0.02 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jan 2026 | Oct 2025 | Jul 2025 | Jan 2025 | Oct 2024 | Jul 2024 | Jan 2024 | Oct 2023 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $17M | $15M | $14M | $17M | $13M | $14M | $12M | $12M |
| Cost of revenue | $9M | $7M | $8M | $7M | $7M | $7M | $8M | $7M |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-276,000 | $185,000 | $-527,000 | $4M | $732,000 | $1M | $-3M | $-2M |
| Net income | $-279,000 | $237,000 | $-466,000 | $4M | $728,000 | $1M | $-3M | $-2M |
| EPS (diluted) | $-0.02 | $0.02 | $-0.03 | $0.31 | $0.05 | $0.09 | $-0.19 | $-0.15 |
Balance sheet (quarterly)
| Metric | Jan 2026 | Oct 2025 | Jul 2025 | Jan 2025 | Oct 2024 | Jul 2024 | Jan 2024 | Oct 2023 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $7M | $9M | $10M | $3M | $3M | $3M | $4M | $6M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $20M | $21M | $21M | $20M | $14M | $13M | $13M | $14M |
| Total assets | $28M | $30M | $31M | $31M | $25M | $25M | $27M | $28M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $24M | $26M | $27M | $25M | $25M | $25M | $29M | $28M |
| Total equity | $4M | $4M | $4M | $5M | $681,000 | $-332,000 | $-2M | $93,000 |